SCTX NASDAQ
Scribe Therapeutics Inc.
1W: -21.1%
1M: -45.7%
YTD: +11.9%
$16.79
-0.39 (-2.24%)
Weekly Expected Move ±19.0%
$10
$14
$17
$20
$23
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.45
Bullish
1 bullish
1 neutral
0 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (10)
Cathie Wood's Ark Invest weekly recap: boosts Meta, Rocket Lab; cuts Tempus AI, CrowdStrike
Scribe Therapeutics Inc. (NASDAQ:SCTX) Stock Rated “Moderate Buy” by Wall Street Analysts
Cathie Wood's weekly recap: buys $25M of CoreWeave, trims $40M in Bitcoin ETF
Cathie Wood's Ark weekly recap: buys Meta, gene-editing stocks while cutting Alphabet
Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI
HC Wainwright Issues Positive Forecast for SCTX Earnings
Brokers Set Expectations for SCTX Q2 Earnings
Scribe Therapeutics Inc. GAAP EPS of -$2.62 beats by $1.15, revenue of $1.92M misses by $1.19M
Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Eli Lilly and Sanofi-backed Scribe surges in public debut